Angelini Pharma at the GOTS Congress: exploring the efficacy of heat and cold therapy in sports medicine
![AP24 G 1030 Congressothermacare](/media/paydw0v0/ap24_g_1030_congressothermacare.jpg?center=0.736998514115899,0.59810540069686413&mode=crop&width=1030&height=302&rnd=133630935376600000&bgcolor=fff)
Heat therapy, a practice that has stood the test of time, offers practical benefits for a variety of musculoskeletal conditions, making it a valuable tool in our field
Prof. Jürgen Freiwald
Angelini Pharma participates in the 39th edition of the GOTS Congress with a symposium on “Heat and Cold Therapy in Sports - When is it Useful?”. The Gesellschaft für Orthopädisch Traumatologische Sportmedizin (GOTS), the second largest global association of sports orthopedists and traumatologists, organizes this event every year. It represents a unique opportunity for international exchange and discussion among experts working in the field of sports orthopedics and traumatology, promoting the discussion on the latest evidence regarding diseases and therapies. This year's edition will take place in Nuremberg, with over 600 participants expected, especially from Germany, Austria, and Switzerland.
THE SYMPOSIUM
Angelini Pharma is organizing the in-depth symposium "Heat and Cold Therapy in Sports - When is it Useful?" at the GOTS Congress, with a particular focus on the effectiveness of heat therapy in the treatment of musculoskeletal pain in sport. The event will feature two high-profile experts: PD Dr. Thilo Hotfiel, MD: Specialist in Sports Orthopaedics and Traumatology and member of the GOTS Advisory Board, and Prof. Dr. Jürgen Freiwald, University Professor of Movement and Training Science at the Bergische Universität Wuppertal. The experts will discuss the best strategies for relieving musculoskeletal pain in acute and chronic phases, emphasizing the importance of a multidisciplinary approach and analyzing the various applications of heat and cold therapy in the treatment of musculoskeletal pain in athletes.
Particular attention will be paid to heat therapy, known for its benefits in the sports context. The symposium will offer speeches on various aspects, including:
- Heat therapy properties and physiological effects
- The effectiveness of heat therapy for different musculoskeletal conditions
- The benefits of heat therapy in reducing the need for musculoskeletal pain medication
- The application of heat therapy before and after active therapies or in combination with them
This event represents an important opportunity to deepen knowledge and discuss best practices in the use of thermal therapies in sports.
ANGELINI PHARMA'S COMMITMENT
Angelini Pharma, with a long tradition of research on pain and inflammation treatment, is committed to constantly improving people's quality of life through innovative solutions. In addition to developing cutting-edge drugs, the company invests in advanced technologies and non-pharmacological solutions such as heat therapy to provide relief from muscle pain. This non-pharmacological approach represents a key element of Angelini Pharma's commitment to the Consumer Health sector, offering effective and personalized treatment options that respond to patients' physical, emotional, and social needs.